oxisuran has been researched along with azathioprine in 1 studies
*Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) [MeSH]
*Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Otterness, IG | 1 |
1 other study(ies) available for oxisuran and azathioprine
| Article | Year |
|---|---|
Comparative activity of CP-17,193 and five established immunosuppressives toward the antigens SRBC and EL4.
Topics: Animals; Antibody Formation; Antigens; Azathioprine; Cyclophosphamide; Erythrocytes; Hemagglutination Tests; Hemolytic Plaque Technique; Immunity, Cellular; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Mice; Mice, Inbred BALB C; Pyrazoles; Pyridines | 1981 |